We are live on ! Find out more

IMUC

ImmunoCellular Therapeutics, Ltd.

IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

31 hedge funds and large institutions have $6.26M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New

Increased

Maintained

Reduced

Closed

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

3% less funds holding

Funds holding: 32 → 31 (-1)

17% less capital invested

Capital invested by funds: $7.54M → $6.26M (-$1.28M)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders

Holders Change

-1

Holders Change %

-3.13%

% of All Funds

0.84%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

$2K

Net Calls

-$2K

Net Calls Change